- STAT+: Up and down the ladder: The latest comings and goingsHired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.STAT · 24d ago↗ source
- After landmark deal, AstraZeneca goes to CSPC again in up to $1.7B pactLess than six months after lining up one of the largest biobucks packages in industry history, AstraZeneca is returning to the same Chinese partner for another drug R&D collaboration. The UK…Endpoints · 24d ago↗ source
- STAT+: What does DeGette’s loss mean for pharma?Colorado Democratic Rep. Diana DeGette, who lost her primary, was knowledgeable about biopharma, if not always a friend to the industry.STAT · 24d ago